‘Killer’ protein paves way for cancer, inflammation treatment – Brisbane Times

“Ultimately, what we want to be able to do is turn it on in diseases where its a benefit, like cancer, and then turn it off for things like autoimmune diseases,” he said.
“Were currently developing the tools to do that, either drugs or antibodies to either block its function or stimulate its function.”
The researchers found that increasing NKG7 production was very beneficial for cancers such as melanoma, where a large immune response from the body was needed.
On the other hand, they found tha…

Click here to view the original article.